The Harvard research funding crisis has sent shockwaves through the academic community, placing vital projects and groundbreaking innovations at a precarious crossroads.Following the Trump administration’s abrupt freeze on approximately $2.2 billion earmarked for Harvard research, prominent faculty members, including Don Ingber from the Wyss Institute, have found their work halted, particularly in the realm of organ-on-a-chip technology.